Company intelligence / Profile preview

Empirical Ventures

Bristol, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Empirical Ventures is a specialist investor in deep science and life sciences, supporting early-stage biotechnology, healthtech, and deeptech ventures. Their portfolio includes companies progressing from pre-clinical research to commercial-stage diagnostics and devices. Notable investments include advancements in mitochondrial therapeutics for neurodegeneration (MitoRx), refrigeration-free biologicals (EnsiliTech), implantable semiconductor technology for neurology (MintNeuro), novel single-molecule diagnostic tools (Exciting Instruments), and CE-marked AI for prostate cancer diagnostics (Lucida Medical)[9][2][1][3][4].

Therapeutic areas: Metabolic DisordersInfectious DiseasesRare DiseasesOncologyNeurology
Modalities: Small moleculeBiologicProteinAntibodyDeviceArtificial intelligence
Industry: Investors

Beyond the preview

Go deeper on Empirical Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Empirical Ventures.

Explore the full profile